The implications from the design of the clinical GLP-1 agonist trials and studies of caloric restriction are that exercise is basically irrelevant.
The article “The New Diet Drugs vs. Exercise: Which Works Better?” discusses the findings from clinical trials on GLP-1 agonists and studies on caloric restriction. It suggests that these trials imply that exercise may have minimal relevance in weight loss compared to the effects of these new diet drugs. The discussion emphasizes the contrasting effectiveness of pharmacological interventions versus physical activity in managing weight and improving health outcomes.
Go to the source and read the whole article: The New Diet Drugs vs. Exercise: Which Works Better?
You must be logged in to post a comment.